UNDERSTANDING HOW EPITOPE BINDING INFLUENCES ANTIBODY DEPENDENT COMPLEMENT ENGAGEMENT FOR THERAPY OF B-CELL MALIGNANCIES

Bondza S, Buijs J, Lux A (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Journal for ImmunoTherapy of Cancer BioMed Central

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: A1-A1

Conference Proceedings Title: JOURNAL FOR IMMUNOTHERAPY OF CANCER

DOI: 10.1136/jitc-2022-ITOC9.2

Authors with CRIS profile

Anja Lux Professur für Integrated Immunology

Involved external institutions

Uppsala University SE Sweden (SE)

How to cite

APA:

Bondza, S., Buijs, J., & Lux, A. (2022). UNDERSTANDING HOW EPITOPE BINDING INFLUENCES ANTIBODY DEPENDENT COMPLEMENT ENGAGEMENT FOR THERAPY OF B-CELL MALIGNANCIES. In JOURNAL FOR IMMUNOTHERAPY OF CANCER (pp. A1-A1). LONDON: BMJ PUBLISHING GROUP.

MLA:

Bondza, S., J. Buijs, and Anja Lux. "UNDERSTANDING HOW EPITOPE BINDING INFLUENCES ANTIBODY DEPENDENT COMPLEMENT ENGAGEMENT FOR THERAPY OF B-CELL MALIGNANCIES." Proceedings of the JOURNAL FOR IMMUNOTHERAPY OF CANCER LONDON: BMJ PUBLISHING GROUP, 2022. A1-A1.

BibTeX: Download